IMVT insiders were on both sides of the trade this year. Buys came to roughly $350 million (one buyer), sales to $16.3 million (ten sellers).
The largest purchase came from Roivant Sciences Ltd. (Director), about $350 million.
226 investment managers listed IMVT in their latest 13F filings (Q2 2026); funds were split between buying and selling. 3 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Stout Jay S | Executive Officer | Sell | 2,213 | $32.06 | $71K | SEC |
| Oct 9, 2026 | Stout Jay S | Executive Officer | Sell | 1,596 | $32.06 | $51K | SEC |
| Oct 9, 2026 | Van Tuyl Christopher | Executive Officer | Sell | 1,327 | $32.06 | $43K | SEC |
| Oct 9, 2026 | Gloria Melanie | COO | Sell | 2,241 | $32.06 | $72K | SEC |
| Oct 5, 2026 | Venker Eric | CEO | Sell | 3,506 | $34.11 | $120K | SEC |
| Sep 25, 2026 | Van Tuyl Christopher | Executive Officer | Sell | 2,846 | $36.36 | $103K | SEC |
| Aug 28, 2026 | Pande Atul | Director | Sell | 1,500 | $43.27 | $65K | SEC |
| Aug 21, 2026 | Gloria Melanie | COO | Sell | 3,056 | $44.16 | $135K | SEC |
| Jul 24, 2026 | Pande Atul | Director | Sell | 1,500 | $39.80 | $60K | SEC |
| Jul 24, 2026 | Girao Tiago | CFO | Sell | 6,798 | $38.69 | $263K | SEC |
| Jul 24, 2026 | Stout Jay S | Executive Officer | Sell | 2,857 | $38.69 | $111K | SEC |
| Jul 10, 2026 | Gloria Melanie | COO | Sell | 106 | $39.99 | $4K | SEC |
| Jul 10, 2026 | Van Tuyl Christopher | Executive Officer | Sell | 1,143 | $39.53 | $45K | SEC |
| Jul 10, 2026 | Stout Jay S | Executive Officer | Sell | 1,399 | $39.53 | $55K | SEC |
| Jul 10, 2026 | Stout Jay S | Executive Officer | Sell | 1,906 | $39.53 | $75K | SEC |
In the last 12 months Immunovant, Inc. insiders made open-market purchases worth about $350 million and sales worth about $16.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in IMVT was filed on 2026-10-09.
226 investment managers reported holding IMVT in SEC Form 13F filings for Q2 2026.
No congressional trades in IMVT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).